Feds Investigating Abbott Over Depakote Marketing
News is out that the federal Department of Justice is investigating Abbott Labs over questions about its marketing of Depakote, its anti-seizure drug that’s also approved for bipolar disorder. It’s not clear what the scope of the investigation is, so stay tuned.
Related posts:
- FDA Staff Urge Review Of Developmental Delay, Autism Linked To Depakote
- FDA Issues Major Birth Defects Warning For Depakote
- Pfizer Settlement Includes Much Off-Label Promotion of Geodon and Kickbacks To Docs For Zoloft
- AstraZeneca To Pay Feds $520 Million To Settle Seroquel Claims
- Study Touts Depakote For ADHD Kids Who Are Disruptive
Posted in Furious Seasons